Coronary Artery Bypass Graft Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

Coronary Artery Bypass Graft Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

The Global Coronary Artery Bypass Graft Market reached a valuation of USD 11.8 billion in 2023 and is anticipated to grow at a CAGR of 7.1% from 2024 to 2032. Coronary artery bypass graft (CABG) is a surgical solution for coronary artery disease (CAD), creating a new pathway for blood flow to the heart using a graft. Typically, this graft comes from a section of a blood vessel in the patient’s body, such as the saphenous vein from the leg or the internal mammary artery from the chest.

The market divides by-products into grafts, retractors, heart positioners, tissue stabilizers, and others, with grafts further segmented into saphenous veins, internal thoracic arteries, and other graft types. In 2023, the grafts segment alone was valued at over USD 3.1 billion. Technological improvements, such as tissue engineering and 3D printing, have advanced graft production, resulting in products that closely mimic natural vessels, enhancing compatibility, lowering rejection rates, and reducing post-operative complications. Innovative materials in grafts, including synthetic, bioengineered, and drug-eluting options, improve durability and biocompatibility, reducing restenosis and supporting better patient recovery outcomes, which, in turn, fosters market expansion.

By method, the coronary artery bypass graft market is segmented into traditional (on-pump) and minimally invasive direct CABG. Traditional CABG, which had a leading revenue share of 55.1% in 2023, remains the preferred choice for complex, multi-vessel disease cases requiring precise control. The rise in CAD globally—driven by factors like sedentary lifestyles, poor diet, diabetes, and hypertension—has led to a growing need for CABG procedures to improve patient outcomes.

U.S. coronary artery bypass graft market exceeded USD 3.5 billion in 2023 and is projected to grow at a CAGR of 6.7% through 2032. U.S. hospitals are adopting advanced surgical techniques, including minimally invasive and robotic-assisted CABG, which offer faster recovery times and fewer post-surgical complications, making the procedure increasingly appealing. The prevalence of multi-vessel disease in the U.S. also contributes to the rising demand for CABG procedures.